Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06263426 · ClinicalTrials.gov registry record · NA

Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

A NA study of HIV, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
13
Study locations

NCT06263426 is a NA study of HIV that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 200 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (54% lower). The trial reports 13 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06263426, a NA study of HIV, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
13
Study locations

Study Summary

This research is being done to better understand rejection in transplant recipients with HIV who receive kidneys from donors with vs without HIV.

Conditions Studied

Interventions

  • OTHER HIV D+/R+
  • OTHER HIV D-/R+

Study Locations (13)

New York

  • New York University - New York
  • Icahn School of Medicine at Mt. Sinai - New York
  • Columbia University - New York
  • Weill Cornell Medical Center - New York

California

  • University of California, Los Angeles - Los Angeles
  • University of California, San Diego - San Diego
  • University of California, San Francisco - San Francisco

Alabama

  • University of Alabama at Birmingham - Birmingham

Illinois

  • Rush University Medical Center - Chicago

Louisiana

  • Ochsner Clinic Foundation - New Orleans

Maryland

  • Johns Hopkins University - Baltimore

Massachusetts

  • Massachusetts General Hospital - Boston

Pennsylvania

  • University of Pittsburgh Medical Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-05-22
Est. Completion 2029-09
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT06263426

The ClinicalTrials.gov registry entry for NCT06263426 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (54% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which HIV D+/R+ is the first listed.

NCT06263426 reports 13 study locations spanning 8 distinct geographic areas - top geographies include New York, California, Alabama.

Frequently Asked Questions

What is clinical trial NCT06263426 about?

NCT06263426 is a clinical study titled "Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)". This research is being done to better understand rejection in transplant recipients with HIV who receive kidneys from donors with vs without HIV.

What is the current status of trial NCT06263426?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-05-22. Estimated completion is 2029-09.

What conditions does trial NCT06263426 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT06263426?

The interventions under investigation include: HIV D+/R+ (OTHER), HIV D-/R+ (OTHER).

Who is sponsoring clinical trial NCT06263426?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06263426 being conducted?

This trial has 13 study locations across Alabama, California, Illinois, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.